Drugs / Hyperpolarized C13
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04346225 | Jul 2020 → Dec 2026 | prostate carcinoma | Ivan de Kouchkovsky, MD | Suspended | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hyperpolarized C13 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04346225 ↗ |
| Modality | Diagnostic / imaging agent | “as Diagnostic Tool” NCT04346225 ↗ |
| Route | Intravenous | “Given by intravenous injection.” NCT04346225 ↗ |